|
Form 20-F ☒
|
Form 40-F ☐
|

|
|
• |
Safety performance at North American Lithium (NAL) remained strong during the June 2026 quarter, with no lost-time injuries recorded and continued improvement in risk management and operational
discipline across the site.
|
|
|
• |
Ore mined remained stable quarter on quarter (QoQ) with 372,938 wet metric tonnes (wmt) mined in line with process plant requirements.
|
|
|
• |
Process plant utilisation remained high at 92% following a record March 2026 quarter and was the third best quarter on record despite a planned shutdown. Strong crushing plant performance continued to support milling utilisation.
|
|
|
• |
The combination of high mill utilisation, throughput, and improved feed grades resulted in lithium recoveries of 71% for the June 2026 quarter, a 5% QoQ improvement.
|
|
|
• |
Spodumene concentrate production increased by 15% QoQ to 54,479 dry metric tonnes (dmt) at an average grade of 5.0%. This was the second-best performance on record and included a new monthly
record of 22,202 dmt produced in May 2026 when utilisation and recoveries peaked at 98% and 73%, respectively.
|
|
|
• |
As previously disclosed1, spodumene sales were 33,977 dmt at an average realised selling price (FOB) of US$921/dmt, resulting in revenue of US$31 million. This was a 39% QoQ
decline in tonnes sold and a 37% decrease in the average realised price per tonne as the Company sold the final tonnes under a multi-year contractual agreement that included a lagged pricing mechanism. This legacy contract has now been
finalised and pricing in Q1 FY27 and beyond is expected to be more representative of spodumene spot prices.
|
|
|
• |
Unit operating costs per tonne sold (FOB) for NAL were US$907/dmt, a 3% increase compared to US$884 in the prior quarter, primarily reflecting the release of higher cost inventory
resulting from the timing of the planned major plant shutdown costs in April and the sustained mining intensity.
|
|
|
• |
Capital expenditure of US$4 million for the June 2026 quarter was related to various planned NAL sustaining capital projects and the NAL Expansion Scoping Study.
|
|
|
• |
Elevra released an Updated Scoping Study for the NAL Expansion evaluating a staged approach which accelerates production growth by two years and more than doubles the project’s incremental post-tax NPV8% to C$969 million
while maintaining total capital expenditure of C$366 million2.
|
|
|
• |
The Company reached a major milestone with the official groundbreaking of the fully funded NAL Expansion and key equipment orders placed to reduce schedule risk3.
|
|
|
• |
Elevra purchased the spodumene concentrate offtake rights held by an investment vehicle managed by Waratah Capital Advisors, giving the Company control over 100% of its pro rata offtake entitlement, which is 60% of Moblan’s annual
production4.
|
|
|
• |
To continue advancing project development, Elevra progressed environmental baseline studies and began preparations for an updated Moblan Scoping Study.
|
|
|
• |
Elevra maintained engagement with the North Carolina Division of Air Quality to progress the project’s air permit while also meeting with local county leadership to provide updates on project activities and reinforce the Company’s
commitment to responsible project development.
|
|
|
• |
In May 2026, Elevra announced a Strategic Financing Package to fully fund the NAL Expansion comprised of a US$196 million (A$275 million) institutional placement and US$102 million (C$145 million) in Convertible Notes to be issued to
the Canada Growth Fund (CGF) across two tranches. The issuance of the Upfront Tranche of Convertible Notes was approved by shareholders at an Extraordinary General Meeting on 16 July 20265 6, with proceeds of approximately US$46 million (C$65 million) from the Upfront Tranche to be received in Q3 CY26. Shareholder
approval will be sought at the appropriate time for the issuance of a further C$80M Conditional Tranche of Convertible Notes. A US$11 million (A$16 million) Share Purchase Plan for eligible retail shareholders was also completed7.
|
|
|
• |
Elevra agreed to sell its interest in the Ewoyaa Project in Ghana to Zhejiang Huayou Cobalt Co., Ltd. (Huayou) for approximately US$71 million in cash (before fees) to streamline the Company’s
growth portfolio and remove future funding obligations. This transaction is expected to complete in Q3 CY268.
|
|
|
• |
Cash at the end of the June 2026 quarter was US$255 million, which did not include the proceeds generated from the sale of the Ewoyaa Project interest or the draw down of the first tranche of the CGF convertible note. Net cash was
US$200 million (March 2026: US$59 million), with the prepayment facility balance of US$55 million (March 2026: US$54 million). The prepayment facility was subsequently reduced by US$9
million in July 2026.
|
|
|
• |
Guidance for FY27 will be provided with FY26 Full Year Results in late August.
|
|
Unit
|
Q4
FY26
|
Q3
FY26
|
QoQ
Variance
|
FY26
|
FY25
|
YoY
Variance
|
|
|
North American Lithium9
|
|||||||
|
Ore mined
|
wmt
|
372,938
|
370,508
|
1%
|
1,471,588
|
1,294,972
|
14%
|
|
Ore processed
|
dmt
|
358,806
|
346,324
|
4%
|
1,398,502
|
1,346,462
|
4%
|
|
Recovery
|
%
|
71
|
66
|
5%
|
67
|
69
|
(2%)
|
|
Concentrate produced
|
dmt
|
54,479
|
47,332
|
15%
|
197,967
|
204,857
|
(3%)
|
|
Concentrate grade produced
|
%
|
5.0
|
5.0
|
—
|
5.0
|
5.3
|
(0.3%)
|
|
Concentrate sold
|
dmt
|
33,977
|
55,526
|
(39%)
|
181,494
|
209,038
|
(13%)
|
|
Average realised selling price (FOB)10
|
US$/dmt
|
921
|
1,453
|
(37%)
|
1,092
|
694
|
57%
|
|
Revenue
|
US$M
|
31
|
81
|
(61%)
|
198
|
145
|
37%
|
|
Unit operating cost per tonne sold (FOB)11
|
US$/dmt
|
907
|
884
|
3%
|
853
|
835
|
2%
|
|
Group
|
|||||||
|
Cash balance
|
US$M
|
255
|
113
|
126%
|
255
|
47
|
440%
|
|
USD : CAD
|
$
|
1.38
|
1.37
|
1%
|
1.38
|
1.40
|
(1%)
|
|
USD : AUD
|
$
|
1.41
|
1.44
|
(2%)
|
1.48
|
1.55
|
(4%)
|




|
|
• |
194,016,029 ordinary fully paid shares;
|
|
|
• |
8,000,000 unquoted options expiring on 31 December 2028 (EX $4.80);
|
|
|
• |
56,678 unquoted options expiring on 12 May 2029 (EX $18.30);
|
|
|
• |
2,457,652 unquoted performance rights (expiring various dates).
|

| • |
All references to dollars and cents are United States currency, unless otherwise stated.
|
| • |
Numbers presented may not add up precisely to the totals provided due to rounding.
|
|
Unit
|
Q4 FY25
|
Q1 FY26
|
Q2 FY26
|
Q3 FY26
|
Q4 FY26
|
|
|
Physicals23
|
||||||
|
Ore mined
|
wmt
|
361,883
|
338,341
|
389,801
|
370,508
|
372,938
|
|
Ore crushed
|
wmt
|
379,353
|
349,698
|
361,485
|
350,202
|
384,307
|
|
Ore processed
|
dmt
|
357,290
|
341,780
|
351,592
|
346,324
|
358,806
|
|
Concentrate produced
|
dmt
|
58,533
|
52,003
|
44,154
|
47,332
|
54,479
|
|
Concentrate sold
|
dmt
|
66,980
|
25,975
|
66,016
|
55,526
|
33,977
|
|
Unit Metrics
|
||||||
|
Average realised selling price (FOB)24
|
US$/dmt
|
682
|
784
|
998
|
1,453
|
921
|
|
Unit operating cost per tonne sold (FOB)25
|
US$/dmt
|
791
|
818
|
812
|
884
|
907
|
|
Production Variables
|
||||||
|
Mill utilisation
|
%
|
93%
|
87%
|
89%
|
94%
|
92%
|
|
Recovery
|
%
|
73%
|
69%
|
62%
|
66%
|
71%
|
|
Concentrate grade produced
|
%
|
5.2%
|
5.2%
|
4.9%
|
5.0%
|
5.0%
|
|
ELEVRA LITHIUM LIMITED
|
||
|
Date: July 28, 2026
|
By:
|
/s/ Dylan Roberts
|
|
Name: Dylan Roberts
|
||
|
Title: Company Secretary and General Counsel
|
||